1. Home
  2. INDP vs IVDA Comparison

INDP vs IVDA Comparison

Compare INDP & IVDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • IVDA
  • Stock Information
  • Founded
  • INDP 2000
  • IVDA 2003
  • Country
  • INDP United States
  • IVDA United States
  • Employees
  • INDP N/A
  • IVDA N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • IVDA Computer Software: Prepackaged Software
  • Sector
  • INDP Health Care
  • IVDA Technology
  • Exchange
  • INDP Nasdaq
  • IVDA Nasdaq
  • Market Cap
  • INDP 6.0M
  • IVDA 6.7M
  • IPO Year
  • INDP N/A
  • IVDA N/A
  • Fundamental
  • Price
  • INDP $12.44
  • IVDA $2.19
  • Analyst Decision
  • INDP Strong Buy
  • IVDA
  • Analyst Count
  • INDP 2
  • IVDA 0
  • Target Price
  • INDP $8.50
  • IVDA N/A
  • AVG Volume (30 Days)
  • INDP 700.9K
  • IVDA 99.5K
  • Earning Date
  • INDP 08-11-2025
  • IVDA 08-13-2025
  • Dividend Yield
  • INDP N/A
  • IVDA N/A
  • EPS Growth
  • INDP N/A
  • IVDA N/A
  • EPS
  • INDP N/A
  • IVDA N/A
  • Revenue
  • INDP N/A
  • IVDA $7,148,449.00
  • Revenue This Year
  • INDP N/A
  • IVDA $340.48
  • Revenue Next Year
  • INDP N/A
  • IVDA N/A
  • P/E Ratio
  • INDP N/A
  • IVDA N/A
  • Revenue Growth
  • INDP N/A
  • IVDA 54.15
  • 52 Week Low
  • INDP $7.56
  • IVDA $1.27
  • 52 Week High
  • INDP $66.64
  • IVDA $8.05
  • Technical
  • Relative Strength Index (RSI)
  • INDP 54.42
  • IVDA 57.79
  • Support Level
  • INDP $9.45
  • IVDA $1.76
  • Resistance Level
  • INDP $11.71
  • IVDA $2.44
  • Average True Range (ATR)
  • INDP 2.07
  • IVDA 0.17
  • MACD
  • INDP 0.19
  • IVDA 0.06
  • Stochastic Oscillator
  • INDP 35.63
  • IVDA 80.82

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About IVDA Iveda Solutions Inc.

Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).

Share on Social Networks: